Description: Microba Life Sciences Limited operates as a gut microbiome analysis company in Australia. It offers Insight, a test for the metagenomic analysis of the gut microbiome; and bespoke health management solutions for partners and practitioners to improve patient care. The company was incorporated in 2017 and is based in Brisbane, Australia.
Home Page: microba.com
MAP Technical Analysis
324 Queen Street
Brisbane,
QLD
4000
Australia
Phone:
61 13 0097 4621
Officers
| Name | Title |
|---|---|
| Dr. Luke Reid | Chief Executive Officer |
| Prof. Gene Tyson | Co-Founder & Non-Executive Director |
| Mr. James Heath | CFO & Company Secretary |
| Prof. Philip Hugenholtz | Co-Founder & Chair of Scientific Advisory Board |
| Prof. Lutz Krause | Chief Scientific Officer |
| Mr. Drew Webb | Chief Marketing Officer |
| Prof. Trent Munro | Senior Vice President of Therapeutics |
| Dr. Nicola Angel | Head of Laboratory Operations |
| Mr. Bernie Woodcroft | Senior Vice President of Platform Solutions |
| Dr. David Wood | Head of Bioinformatics Operations |
Exchange: AU
Country: AU : Australia
Currency: Australian Dollar (A$)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Providers & Services |
| GIC Sub-Industry: | Health Care Services |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.9559 |
| Price-to-Sales TTM: | 6.6677 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |